Dokter Piet Vandeweghe - Huisarts
0808.269.821 · rovalta.com · 27/09/2026
Dokter Piet Vandeweghe - Huisarts
Company — Normal situation.
Financial year 2023 · Closed on 20/03/2023
Overview
Identity
Source · BCE/KBODokter Piet Vandeweghe - Huisarts is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0808.269.821
- Legal form
- Private company with limited liability
- Contributed capital
- 0,00 €
- Latest accounts
- 20/03/2023
Financials
Source · NBB, 14 filingsTrend over 3 financial years
| 2023 | 2022 | 2010 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | 1,1 k € | -95.7% | 26,2 k € | +19.9% | 21,9 k € |
| EBITDA | 239,1 € | -99.0% | 22,9 k € | +20.5% | 19 k € |
| Operating result | 239,1 € | -97.2% | 8,7 k € | +126% | -33,3 k € |
| Net result | -1,2 k € | -117% | 7,1 k € | +110% | -68,3 k € |
| Balance sheet | |||||
| Equity | 0 € | -100% | 229,2 k € | +3711% | -6,3 k € |
| Total assets | 228 k € | -29.3% | 322,5 k € | -40.4% | 540,6 k € |
| Cash | 577,9 € | -97.5% | 23,4 k € | +70.1% | 13,7 k € |
| Debts | 228 k € | +157% | 88,8 k € | -83.8% | 547 k € |
Board of directors
Source · NBB, accounts to 20/03/20231 active · 6 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Piet Leon Vandeweghe | Director | 04/12/2008 → 20/03/2023 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Piet Vandeweghe | Manager | since 04/12/2010 | 000 |
Therese Cosyns | Manager | since 04/12/2010 | |
Piet Leon Vandeweghe | Director | since 04/12/2008 | |
Piet Leon Vandeweghe | Manager | since 04/12/2008 |
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 | 01/07/2018 | 01/07/2017 |
| Closing of the financial year | 20/03/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 | 30/06/2019 | 30/06/2018 |
| Length of the financial year | 9 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/10/2023 | 16/01/2023 | 28/01/2022 | 28/01/2021 | 06/01/2020 | 23/01/2019 |
| General meeting | 20/03/2023 | 16/12/2022 | 31/12/2021 | 31/12/2020 | 20/12/2019 | 28/12/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 20/03/2023 | 20/03/2023 | 27/10/2023 | Dutch | |
| Micro model | 30/06/2022 | 16/12/2022 | 16/01/2023 | Dutch | |
| Micro model | 30/06/2021 | 31/12/2021 | 28/01/2022 | Dutch | |
| Micro model | 30/06/2020 | 31/12/2020 | 28/01/2021 | Dutch | |
| Micro model | 30/06/2019 | 20/12/2019 | 06/01/2020 | Dutch | |
| Micro model | 30/06/2018 | 28/12/2018 | 23/01/2019 | Dutch | |
| Micro model | 30/06/2017 | 15/12/2017 | 26/01/2018 | Dutch | |
| Abridged model | 30/06/2016 | 16/12/2016 | 24/01/2017 | Dutch | |
| Abridged model | 30/06/2015 | 18/12/2015 | 05/01/2016 | Dutch | |
| Abridged model | 30/06/2014 | 19/12/2014 | 30/01/2015 | Dutch | |
| Abridged model | 30/06/2013 | 31/01/2014 | 06/03/2014 | Dutch | |
| Abridged model | 30/06/2012 | 25/01/2013 | 22/02/2013 | Dutch | |
| Abridged model | 30/06/2011 | 27/01/2012 | 13/02/2012 | Dutch | |
| Abridged model | 30/06/2010 | 31/01/2011 | 01/03/2011 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 20/03/20231 active · 6 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Piet Leon Vandeweghe | Director | 04/12/2008 → 20/03/2023 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Piet Vandeweghe | Manager | since 04/12/2010 | 000 |
Therese Cosyns | Manager | since 04/12/2010 | |
Piet Leon Vandeweghe | Director | since 04/12/2008 | |
Piet Leon Vandeweghe | Manager | since 04/12/2008 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution12/04/2023RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
- Mandates01/06/2017BENAMING - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
- Other17/12/2008RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023-1,2 k €↓
- 2023Name changeDokter Piet Vandeweghe - Huisarts in vereffening
- 2022Annual accounts 20227,1 k €↑
- 2010Annual accounts 2010-68,3 k €
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dokter Piet Vandeweghe - Huisarts in vereffening | accounts 2023 | Accounts 2023 · 2023-00494655 |
| Dokter Piet Vandeweghe - Huisarts | accounts 2022 | Accounts 2022 · 2023-20558541 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.